REDOXIS

Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions. They provide in vivo of RA, MS, GBS and SLE. In addition, they have a fully equipped lab with capacity to perform in vitro and ex vivo follow up assays and a wide range of immunology assays to provide you everything form MoA studies to PK and in vivo efficacy studies. Please visit www.redoxis.com for further information or contact us directly for quotes and discussion on model selection (free of charge).